In a report released today, Jailendra Singh from Truist Financial maintained a Buy rating on Icon (ICLR – Research Report). The company’s ...
Clinical research conductor ICON Plc downplayed impacts from demand softness from the pharmaceutical and biotechnology ...
The market expects Icon PLC (ICLR) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook is ...